Cannabis Science and Technology® is pleased to announce the addition of André Silva, MSc Forensic Science to its editorial advisory board (EAB).
André Silva graduated in 2018 with a master’s degree in Forensic Science from Anglia Ruskin University in Cambridge, England where he also worked as an Associate Lecturer. He is currently a Field Marketing Specialist for Reference Materials for Merck.
Silva previously worked as a portfolio specialist for the same group of products, supporting customers in Spain and Portugal at both a technical and commercial level. He has also been involved in multiple initiatives around the cannabis testing industry on topics ranging from laboratory quality control to regulatory and legal matters.
To maximize his free time, Silva fills his schedule with sports, literature, podcasts, travelling, and any hobbies that spark his curiosity.
Welcome to the board, André Silva!
Cannabis Science and Technology® also recently announced several other new members to its EAB:
For a complete list of the Cannabis Science and Technology® Editorial Advisory Board please visit: www.cannabissciencetech.com/cannabis-science-and-technology-editorial-advisory-board.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.